BRIGHT MINDS BIOSCIENCES INC
DRUG·10919W405·US·Common Stock·Healthcare - Biotechnology-Activist
DRUG (BRIGHT MINDS BIOSCIENCES INC) is held by 61 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($48.2M), DRIEHAUS CAPITAL MANAGEMENT LLC ($30.4M), BALYASNY ASSET MANAGEMENT L.P. ($24.2M). Net institutional sentiment: Bullish.
61
Holders
(1 Elite)
$264M
Total Value
81% (63)
Consensus
51 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Apr 30, 2026 · Activists Aug 14, 2026 · Congress none
ActivistCACormorant Asset Management, LP9.2%Aug 14, 2026
ActivistADAdage Capital Management, L.P.3.4%Aug 12, 2026
ActivistIMIan McDonald13.7%Jul 2, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 69
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer